Corneal Ulcers - Pipeline Review, H2 2015

Publisher Name :
Date: 09-Dec-2015
No. of pages: 39
Price : Single User: US $ 2000  US $ 1700 Corporate User: US $ 6000  US $ 4800
Inquire Before Buying
This report is available at 15% Discount for Single User License and 20% Discount for Corporate Users License till 01 September 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Global Markets Direct's, ‘Corneal Ulcers - Pipeline Review, H2 2015', provides an overview of the Corneal Ulcers's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Corneal Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Corneal Ulcers and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Corneal Ulcers

  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved in the therapeutics development for Corneal Ulcers and enlists all their major and minor projects

  • The report summarizes all the dormant and discontinued pipeline projects

  • A review of the Corneal Ulcers products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • A detailed assessment of monotherapy and combination therapy pipeline projects

  • Coverage of the Corneal Ulcers pipeline on the basis of target, MoA, route of administration and molecule type

  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Identify and understand important and diverse types of therapeutics under development for Corneal Ulcers

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Devise corrective measures for pipeline projects by understanding Corneal Ulcers pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

This report is available at 15% Discount for Single User License and 20% Discount for Corporate Users License till 01 September 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Corneal Ulcers - Pipeline Review, H2 2015

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Corneal Ulcers Overview 6
Therapeutics Development 7
Pipeline Products for Corneal Ulcers - Overview 7
Pipeline Products for Corneal Ulcers - Comparative Analysis 8
Corneal Ulcers - Therapeutics under Development by Companies 9
Corneal Ulcers - Therapeutics under Investigation by Universities/Institutes 10
Corneal Ulcers - Pipeline Products Glance 11
Early Stage Products 11
Corneal Ulcers - Products under Development by Companies 12
Corneal Ulcers - Products under Investigation by Universities/Institutes 13
Corneal Ulcers - Companies Involved in Therapeutics Development 14
Amakem NV 14
Digna Biotech, S.L. 15
Lee's Pharmaceutical Holdings Limited 16
Corneal Ulcers - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Target 18
Assessment by Mechanism of Action 20
Assessment by Route of Administration 22
Assessment by Molecule Type 24
Drug Profiles 26
AMA-0526 - Drug Profile 26
Mechanism of Action 26
R&D Progress 26
disitertide - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
LQ-7 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
P-17 - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Small Molecules for Parasitic Corneal Ulcers - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
ZK-003 - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Corneal Ulcers - Recent Pipeline Updates 35
Corneal Ulcers - Dormant Projects 36
Corneal Ulcers - Discontinued Products 37
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 38
Disclaimer 39

List of Tables

Number of Products under Development for Corneal Ulcers, H2 2015 7
Number of Products under Development for Corneal Ulcers - Comparative Analysis, H2 2015 8
Number of Products under Development by Companies, H2 2015 9
Number of Products under Investigation by Universities/Institutes, H2 2015 10
Comparative Analysis by Early Stage Products, H2 2015 11
Products under Development by Companies, H2 2015 12
Products under Investigation by Universities/Institutes, H2 2015 13
Corneal Ulcers - Pipeline by Amakem NV, H2 2015 14
Corneal Ulcers - Pipeline by Digna Biotech, S.L., H2 2015 15
Corneal Ulcers - Pipeline by Lee's Pharmaceutical Holdings Limited, H2 2015 16
Assessment by Monotherapy Products, H2 2015 17
Number of Products by Stage and Target, H2 2015 19
Number of Products by Stage and Mechanism of Action, H2 2015 21
Number of Products by Stage and Route of Administration, H2 2015 23
Number of Products by Stage and Molecule Type, H2 2015 25
Corneal Ulcers Therapeutics - Recent Pipeline Updates, H2 2015 35
Corneal Ulcers - Dormant Projects, H2 2015 36
Corneal Ulcers - Discontinued Products, H2 2015 37

List of Figures

Number of Products under Development for Corneal Ulcers, H2 2015 7
Number of Products under Development for Corneal Ulcers - Comparative Analysis, H2 2015 8
Number of Products under Development by Companies, H2 2015 9
Comparative Analysis by Early Stage Products, H2 2015 11
Assessment by Monotherapy Products, H2 2015 17
Number of Products by Targets, H2 2015 18
Number of Products by Stage and Targets, H2 2015 18
Number of Products by Mechanism of Actions, H2 2015 20
Number of Products by Stage and Mechanism of Actions, H2 2015 20
Number of Products by Routes of Administration, H2 2015 22
Number of Products by Stage and Routes of Administration, H2 2015 22
Number of Products by Molecule Types, H2 2015 24
Number of Products by Stage and Molecule Types, H2 2015 24
  • Global Eye Drops & Lubricants Market Professional Survey Report 2017
    Published: 15-Aug-2017        Price: US 3500 Onwards        Pages: 106
    This report studies Eye Drops & Lubricants in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Bausch + Lomb - Abbott - Clear Eyes - Sager Pharma - A......
  • Global Ophthalmic Drugs Sales Market Report 2017
    Published: 11-Aug-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the global Ophthalmic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units) , revenue (Million USD) , market share and growth rate of Ophthalmic Drugs for these regions, from 2012 to 2022 (forecast) , covering - United States - China - Europe - Japan......
  • Global Ophthalmic Drugs Market Research Report 2017
    Published: 07-Aug-2017        Price: US 2900 Onwards        Pages: 109
    In this report, the global Ophthalmic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Ophthalmic Drugs in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - J......
  • Global Ophthalmology Amniotic Membrane Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 04-Aug-2017        Price: US 3480 Onwards        Pages: 116
    Amniotic membrane (AM) can function in the eye as a basement membrane substitute or as a temporary graft. It has anti-inflammatory and anti-scarring effects and contains growth factors that promote epithelial wound healing on the surface of the eye. Scope of the Report: This report focuses on the Ophthalmology Amniotic Membrane in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market ba......
  • China Eye Drops & Lubricants Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022
    Published: 04-Aug-2017        Price: US 4480 Onwards        Pages: 121
    Eye drops are saline-containing drops used as an ocular route to administer. Depending on the condition being treated, they may contain steroids, antihistamines, sympathomimetics, beta receptor blockers, parasympathomimetics, parasympatholytics, prostaglandins, nonsteroidal anti-inflammatory drugs (NSAIDs), antibiotics, antifungal, or topical anesthetics. Eye drops sometimes do not have medications in them and are only lubricating and tear-replacing solutions. Scope of the......
  • 2017 Top 5 Artificial Tears Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 03-Aug-2017        Price: US 4960 Onwards        Pages: 168
    "This report will be delivered in 2-3 business days after the order is placed." The Global Artificial Tears market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Artificial Tears in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Artificial Tears Players in each ......
  • 2017-2022 China Artificial Tears Market Report (Status and Outlook)
    Published: 03-Aug-2017        Price: US 3360 Onwards        Pages: 117
    "This report will be delivered in 2-3 business days after the order is placed." The Artificial Tears market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include Allergan Alcon (Novartis) Bausch & Lomb Abbott Santen Pharmaceutical......
  • 2017-2022 Global Top Countries Artificial Tears Market Report
    Published: 03-Aug-2017        Price: US 4960 Onwards        Pages: 168
    "This report will be delivered in 2-3 business days after the order is placed." The Global Artificial Tears market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Artificial Tears in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, ......
  • 2017-2022 India Artificial Tears Market Report (Status and Outlook)
    Published: 03-Aug-2017        Price: US 3360 Onwards        Pages: 117
    "This report will be delivered in 2-3 business days after the order is placed." The Artificial Tears market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In India market, the top players include Allergan Alcon (Novartis) Bausch & Lomb Abbott Santen Pharmaceutical......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs